Envestnet Portfolio Solutions
ALNY icon

Envestnet Portfolio Solutions’s Alnylam Pharmaceuticals ALNY Stock Holding History

Envestnet Portfolio Solutions’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Sell
4,635
-123
-3% -$37.1K 0.01% 589
2026
Q1 		$1.57M Buy
4,758
+413
+10% +$141K 0.01% 513
2025
Q4 		$1.73M Buy
4,345
+3,018
+227% +$1.34M 0.01% 580
2025
Q3 		$605K Buy
1,327
+163
+14% +$66.4K ﹤0.01% 955
2025
Q2 		$380K Buy
1,164
+297
+34% +$82.2K ﹤0.01% 1232
2025
Q1 		$234K Sell
867
-1,195
-58% -$307K ﹤0.01% 1413
2024
Q4 		$485K Buy
2,062
+880
+74% +$231K ﹤0.01% 1258
2024
Q3 		$325K Buy
1,182
+43
+4% +$11.2K ﹤0.01% 1406
2024
Q2 		$277K Sell
1,139
-270
-19% -$42.6K ﹤0.01% 1425
2024
Q1 		$211K Buy
1,409
+41
+3% +$6.84K ﹤0.01% 1545
2023
Q4 		$262K Buy
1,368
+89
+7% +$15.2K ﹤0.01% 1366
2023
Q3 		$227K Buy
+1,279
New +$244K ﹤0.01% 1375

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Envestnet Portfolio Solutions's ALNY Position: Q2 2026 in Review

Envestnet Portfolio Solutions reduced its Alnylam Pharmaceuticals (ALNY) stake by 2.6% in Q2 2026, selling an estimated $37.1K and leaving 4,635 shares worth $1.4M. The position accounts for 0.01% of the portfolio, ranked #589.

Envestnet Portfolio Solutions first reported a position in ALNY in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.73M in Q4 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Envestnet Portfolio Solutions held 4,635 shares of Alnylam Pharmaceuticals worth $1.4M as of Q2 2026.
  • Envestnet Portfolio Solutions sold 123 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $37.1K.
  • Alnylam Pharmaceuticals made up 0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #589 holding.
  • Envestnet Portfolio Solutions first reported a position in Alnylam Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's Alnylam Pharmaceuticals position peaked at $1.73M in Q4 2025.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.